Alpha Crest Capital Management LLC Atri Cure, Inc. Transaction History

Alpha Crest Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$38.25 - $52.62 $755,514 - $1.04 Million	19,752 New	19,752 $772,000
Q2 2022 Aug 11, 2022	SELL	$35.1 - $66.01 $183,186 - $344,506	-5,219 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$57.43 - $71.39 $299,727 - $372,584	5,219 New	5,219 $343,000
Q4 2021 Feb 09, 2022	SELL	$63.4 - $87.14 $228,683 - $314,313	-3,607 Closed	0 $0
Q3 2021 Nov 10, 2021	BUY	$69.28 - $84.46 $249,892 - $304,647	3,607 New	3,607 $251,000
Q1 2021 May 13, 2021	SELL	$53.79 - $66.98 $801,471 - $998,002	-14,900 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$34.56 - $57.55 $186,382 - $310,367	5,393 Added 56.73%	14,900 $829,000
Q3 2020 Nov 12, 2020	BUY	$38.36 - $46.91 $364,688 - $445,973	9,507 New	9,507 $379,000

212

49.7M

12K

7.2K

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.66B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.